# VERICEL CORPORATION (VCEL) FY2026 YTD Q2 P&L / Income Statement

- Company: VERICEL CORPORATION (VCEL)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0001628280-26-050836
- Page: https://plicit.ai/financials/vcel/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/vcel-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Sales Channel

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Contract with Customer, Sales Channel. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 145,882,000 US dollars
- **Cost of product sales**: 40,214,000 US dollars
- **Gross profit**: 105,668,000 US dollars
- **Total operating expenses**: 113,298,000 US dollars
- **Income (loss) from operations**: negative 7,630,000 US dollars
- **Total other income**: 3,534,000 US dollars
- **Income before income taxes (calculated)**: negative 4,096,000 US dollars
- **Net income (loss)**: negative 4,096,000 US dollars
- **M A C I Implants and kits**: 121,904,000 US dollars
- **Biopsy kits - Directly to consumer**: 1,220,000 US dollars
- **Epicel - Directly to consumer**: 21,289,000 US dollars
- **Undisclosed (calculated)**: 1,469,000 US dollars
- **Selling, general and administrative**: 97,701,000 US dollars
- **Research and development**: 15,597,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.